May 30, 2013 — CardioKinetix Inc. announced the transmission of a live satellite feed of a clinical case using the catheter-based Parachute Device.
The Parachute procedure was performed by Dr. Martyn Thomas, M.D., chairman of cardiology at St. Thomas’ Hospital in London, England, with assistance from Dr. Hüseyin Ince, professor of medicine, University Hospital Rostock, Germany.
After a heart attack, many patients experience enlargement of their left ventricle causing a decrease in cardiac output resulting in heart failure symptoms such as shortness of breath. Treatment options for patients whose ventricle has enlarged are limited. The Parachute device offers the first, minimally invasive, catheter-based treatment to partition the damaged muscle, excluding the non-functional heart segment from the healthy, functional segment to decrease the overall volume of the left ventricle and restore its geometry and function.
The Parachute Ventricular Partitioning Device is a minimally invasive treatment for patients with heart failure caused by damage to the heart muscle following a heart attack. Clinical data demonstrates improved overall cardiac function and quality of life for patients treated with the Parachute device.
Through a small catheter inserted in the femoral artery, the Parachute implant is deployed in the left ventricle to partition the damaged muscle, excluding the non-functional heart segment from the healthy, functional segment to decrease the overall volume of the left ventricle and restore its geometry and function. This minimally invasive procedure is performed in the catheterization laboratory under conscious sedation.
For more information: www.cardiokinetix.com
November 14, 2025 
